Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.49 AUD | -4.85% | -16.95% | -14.04% |
May. 28 | Opthea Limited Completes Enrollment in Pivotal Phase 3 Clinical Program with Sozinibercept in Wet AMD | CI |
May. 28 | Opthea Completes Enrollments in COAST, ShORe Trials | MT |
- Stock Market
- Equities
- OPT Stock
- News Opthea Limited
- Analyst Reco.